Where to be

10+ can't-miss Houston business and innovation events for October

Check out these conferences, pitch competitions, networking, and more. Getty Images

October is another busy one for Houston innovation. Data-focused conferences, a rescheduled grand opening for The Cannon, and so much more.

If you know of innovation-focused events for this month or next, email me at natalie@innovationmap.com with the details and subscribe to our daily newsletter that sends fresh stories straight to your inboxes every morning.

October 2 — Startup Communication: Post Funding Investor Relations with Eric Danziger

Join Eric Danziger, chief revenue officer at Innowatts, on discussing post-funding investor relations. Danziger has been in the cleantech and smart grid industry for the past 10 years, and Innowatts closed its $18.2 million round earlier this year.

Details: The event is from 5:30 to 7 pm on Wednesday, October 2, at Station Houston (1301 Fannin Street, #2440). Learn more.

October 3 — Raising That First Round with Steve Gray, ATX Venture Partners

Where do you start? This workshop will cover the basics of preparation for that first round of capital raising. There is a rhythm to fundraising, but more importantly, the preparation is vital. Every goal to which you aspire must have a plan and fundraising is no different. At this workshop, Steve Gray of ATX Venture Partners will discuss some lessons learned over the years as well as share ideas on what works and what doesn't.

Details: The event is from 5:30 to 7 pm on Thursday, October 3, at Station Houston (1301 Fannin Street, #2440). Learn more.

October 3 — Growth Tour: Houston

Join Alice, Salesforce Essentials, and the Houston small business community for an unforgettable morning of workshops, networking, and real takeaways to help you reach your goals and strengthen your business.

Details: The event is from 8:30 am to 1 pm on Thursday, October 3, at The Space HTX (2005 Commerce St). Learn more.

October 4 — Houston Next: ERG Summit 2019

To reflect Houston's unique position as the most diverse city in the nation, the Greater Houston Partnership is hosting the Houston NEXT: An ERG Summit with a focus on corporate culture and talent. Join business leaders, HR executives, diversity and inclusion officers and ERG leaders for thoughtful conversations on building diverse and inclusive workplaces.

Details: The event is from 10:30 am to 4:30 pm on Friday, October 4, at Marriott Marquis (1777 Walker Street). Learn more.

October 8 — The Dolphin Tank: Houston

The Dolphin Tank is a "friendly-feedback" pitch session for women entrepreneurs. Springboard Enterprises Dolphin Tank® programs are "helpful feedback-driven" pitch sessions for entrepreneurs to receive constructive insights from knowledgeable professionals. Dolphin Tanks aren't about sharks, piranhas, dragons, or competing for the best idea – they're about channeling the expertise of the people in the room.

Details: The event is from 6 to 8 pm on Tuesday, October 8, at Lilie Lab (Rice University).Learn more.

October 9 — Founders Bootcamp: A Roadmap For Your Startup

JLabs is sitting down with local seasoned investors and entrepreneurs to take a deep dive into key topics designed to equip you with a roadmap for elevating your startup, no matter what stage, into a great company and we'll be swapping war stories along the way.

Details: The event is from 11:30 am to 1 pm on Wednesday, October 9, at JLabs @ TMC (2450 Holcombe Blvd.). Learn more.

October 8-16 — Sesh Coworking

Houston's first female-focused coworking popup event is taking over the town with networking, growth opportunities, and more. Day passes start at $25.

Details: The event is from Tuesday, October 8, to Wednesday, October 16, at Sharespace (1120 Naylor St). Learn more.

October 10 — DataCon Houston

This annual data-focused event is a social and networking opportunity combined with educational programming for business technology.

Details: The event is from 8 am to 8 pm on Thursday, October 10, at TopGolf (1030 Memorial Brook Boulevard). Learn more.

October 17 — Lunch & Learn: CPRIT Information Session


Join the CPRIT team at JLABS to learn about CPRIT's grant funding opportunities available to companies that are developing cancer-focused therapeutics, diagnostics/devices, tools and other non-traditional oncology products.

Details: The event is from 11:30 am to 1 pm on Thursday, October 17, at JLabs @ TMC (2450 Holcombe Blvd.). Learn more.

October 17 — Ignite Healthcare's Annual Fire Pitch Event

The Ignite Healthcare Network Fire Pitch Competition is held each year to encourage innovation in emerging women-led healthcare companies. The program provides an opportunity for women entrepreneurs to engage with advisors, potential customers, and investors to accelerate and refine the growth of their companies.

Details: The event is from 5 to 8:30 pm on Thursday, October 17, at JLabs @ TMC (2450 Holcombe Blvd.) Learn more.

October 17 — JLABS x UH: Startup Pains: From Academia to Startup (Med Device)

JLABS and the University of Houston Technology Bridge present a special installment of Startup Pains, a monthly talk given by entrepreneurs who share their journey of launching a company and overcoming unanticipated obstacles in order to find success in their industry.

Details: The event is from 5 to 7 pm on Thursday, October 17, at UH Technology Bridge, Building 4, Floor 2 (5000 Gulf Freewa7).

October 24 — Central Houston's Annual Innovatech Meeting

This year's program advances the conversation on how not only build, but sustain and support successful and robust innovation ecosystems. Attending the event will be a group of nationally known experts in the fields of placemaking, startup incubators, venture capital and entrepreneurship, and guest speakers will include Houston Mayor Sylvester Turner, Harris Country Judge Lina Hidalgo, Central Houston's President Bob Eury, and Central Houston's Board Chair, Scott Prochazaka, who is the president and CEO of CenterPoint Energy, will inaugurate the meeting.

Details: The event is from 11:30 am to 1 pm on Thursday, October 24, at Lanier Grand Ballroom at the Hilton Americas (1600 Lamar St.). Learn more.

October 24 — The Cannon Grand Opening

The Cannon, an entrepreneurial hub in West Houston, is celebrating its new digs. Join the party to learn about coworking at The Cannon, to network with Houston's innovation ecosystem, and more. Note: This event was pushed back due to Tropical Storm Imelda's flooding across Houston.

Details: The event is from 4 to 9 pm on Thursday, October 24, at The Cannon (1336 Brittmoore Road). Invite only.

October 27 — Implicit Bias Workshop

Impact Hub Houston and The Cannon believe that equitable organizations and equitable opportunities stem from a community of equity-focused leaders, but that is a mindset that must be developed. Through this workshop, participants will develop a shared language around diversity, equity, and inclusion, and understand the importance of these concepts when creating changing and lasting impact.

Details: The event is from 1 to 5 pm on Sunday, October 27, at The Cannon (1336 Brittmoore Road). Learn more.

October 29 — Houston Startup Happy Hour

Mix and mingle with the city's local entrepreneurs, investors, and more. The event is free to attend, but space is limited. Happy hour specials are available all night for attendees.

Details: The event is from 6 to 9 pm on Tuesday, October 29, at Poitin Bar and Kitchen (2313 Edwards Street). Learn more.

October 31 — State of Texas Medical Center

This luncheon focuses on TMC's role in advancing life sciences. Home to the brightest minds in medicine, TMC nurtures cross-institutional collaboration, creativity and innovation. Houston is not only recognized as a global leader in health care delivery and research, but also as an emerging center for biotech commercialization.

Details: The event is from 10:30 am to 1:30 pm on Thursday, October 31, at Marriott Marquis (1777 Walker Street). Learn more.

Trending News

Building Houston

 
 

Tvardi Therapeutics Inc. has fresh funds to support its drug's advancement in clinical trials. Photo via Getty Images

A Houston-based clinical-stage biopharmaceutical company has raised millions in its latest round.

Tvardi Therapeutics Inc. closed its $74 million series B funding round led by new investors New York-based Slate Path Capital, Florida-based Palkon Capital, Denver-based ArrowMark Partners, and New York-based 683 Capital, with continued support and participation by existing investors, including Houston-based Sporos Bioventures.

"We are thrilled to move out of stealth mode and partner with this lineup of long-term institutional investors," says Imran Alibhai, CEO at Tvardi. "With this financing we are positioned to advance the clinical development of our small molecule inhibitors of STAT3 into mid-stage trials as well as grow our team."

Through Slate Path Capital's investment, Jamie McNab, partner at the firm, will join Tvardi's board of directors.

"Tvardi is the leader in the field of STAT3 biology and has compelling proof of concept clinical data," McNab says in the release. "I look forward to partnering with the management team to advance Tvardi's mission to develop a new class of breakthrough medicines for cancer, chronic inflammation, and fibrosis."

Tvardi's latest fundraise will go toward supporting the company's products in their mid-stage trials for cancer and fibrosis. According to the release, Tvardi's lead product, TTI-101, is being studied in a Phase 1 trial of patients with advanced solid tumors who have failed all lines of therapy. So far, the drug has been well-received and shown multiple durable radiographic objective responses in the cancer patients treated.

Dr. Keith Flaherty, who is a member of Tvardi's scientific advisory board and professor of medicine at Harvard Medical School, offered his support of the company.

"STAT3 is a compelling and validated target. Beyond its clinical activity, Tvardi's lead molecule, TTI-101, has demonstrated direct downregulation of STAT3 in patients," he says in the release. "As a physician, I am eager to see the potential of Tvardi's molecules in diseases of high unmet medical need where STAT3 is a key driver."

Trending News